Clinical trial

Renin-Angiotensin-Aldosterone System Inhibitors, Hypertension, and COVID-19

NCT04374695

StatusUNKNOWN

Study typeOBSERVATIONAL

Start date2020-05-01

PhaseN/A

Study timeline

Study start (estimated)2020-05-01Date precision: day

Registry last updated2020-05-05

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

COVID-19unresolved

Interventions

Sponsors & collaborators

Versailles Hospitallead sponsor

Bernard LIVAREK, MD, Cardiology department, Versailles Hospitalcollaborator

Jean-Paul BERESSI, MD, Department of diabetology, Versailles Hospitalcollaborator

Mehrsa KOUKABI FRADELIZZI, MD, Emergency department, Versailles Hospitalcollaborator

Floriane GILLES, MD, Cardiology department, Versailles Hospitalcollaborator

Alisson BERTRAND, Cardiology department, Versailles Hospitalcollaborator

Marie DE TOURNEMIRE, Cardiology department, Versailles Hospitalcollaborator

Victorien MONGUILLON, Cardiology department, Versailles Hospitalcollaborator

Maeva PASQUALINI, Cardiology department, Versailles Hospitalcollaborator

Alix PREVOT, Cardiology department, Versailles Hospitalcollaborator

Guillaume ROGER, Cardiology department, Versailles Hospitalcollaborator

Joseph SABA, Cardiology department, Versailles Hospitalcollaborator

Joséphine SOLTANI, Cardiology department, Versailles Hospitalcollaborator

Jean-François PROST, Cardiology department, Versailles Hospitalcollaborator

Cécile LAUREANA, Department of medical information, Versailles Hospitalcollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04374695 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.